(Continuation news of ACI): On the other hand, cost of borrowing increased due to additional funding for working capital and strategic investments for supporting business growth. Overall, the consolidated EPS was Taka (4.18) during the period against Taka (9.11) of SPLY. NOCFPS during the period was Taka (68.02) against Taka (83.14) as a result of the movement in the working capital. (end)

(Continuation news of ACI): Reasons for significant deviations: During the nine months ended on 31 March 2026, the Group achieved a 15% revenue growth which was contributed by a number of businesses as demonstrated in Consolidated Operating Segments in Annexure A. During the period, increase in gross profit exceeded the increase in operating expenses driven by growth in key segments. (cont.2)

(Q3 Un-audited): Consolidated EPS was Tk. (4.91) for January-March 2026 as against Tk. (1.12) for January-March 2025; Consolidated EPS was Tk. (4.18) for July 2025-March 2026 as against Tk. (9.11) for July 2024-March 2025. Consolidated NOCFPS was Tk. (68.02) for July 2025-March 2026 as against Tk. (83.14) for July 2024-March 2025. Consolidated NAV per share was Tk. 85.78 as on March 31, 2026 and Tk. 91.64 as on June 30, 2025. (cont.1)

The company has informed that the Board of Directors of the Company in its meeting held on 29 April 2026 approved the formation of a joint-venture company under the title of "Deli ACI Bangladesh Limited" having an authorized capital of BDT 100 (One Hundred) Crore and a paid up capital of BDT 27 (Twenty-Seven) Crore wherein Advanced Chemical Industries PLC shall hold 50% shares, subject to the approval of the concerned authority.

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 29, 2026 at 4:00 pm to consider, among others, Un-Audited Financial Statements for the Third Quarter (Q3) period ended March 31, 2026.